openPR Logo
Press release

Venous Thromboembolism Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Quercis, Ono Pharma, Anthos, Bristol Myers Squibb, Yuhan Corp, Supergene, Tasly, GlycoMimetics

10-12-2023 09:26 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Venous Thromboembolism Pipeline Analysis (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Venous Thromboembolism therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Venous Thromboembolism Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Venous Thromboembolism Therapeutics Market.

The report provides a detailed description of the Venous Thromboembolism drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Venous Thromboembolism Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/venous-thromboembolism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Venous Thromboembolism Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Venous Thromboembolism therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Venous Thromboembolism treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Venous Thromboembolism drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Venous Thromboembolism treatment market.

Learn More about the Clinical and Commercial Development Activities in the Venous Thromboembolism Therapeutics Domain:
https://www.delveinsight.com/report-store/venous-thromboembolism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Venous Thromboembolism Therapeutics Analysis
Venous thromboembolism is a life-threatening medical condition that requires immediate medical treatment. Treatment primarily focuses on breaking the clots and preventing further formation of clots. Treatment of Venous Thromboembolism includes blood-thinning agents such as Medication (Anticoagulants, Thrombolytic Agents, Factor Xa Inhibitors, Thrombin Inhibitors). Mechanical devices (compression stockings), and Surgical treatment (Pulmonary embolectomy, Vena caval interruption) are also used in the advance stage of Venous thromboembolism.

Medical therapy for the treatment of Venous thromboembolism includes anticoagulants (heparin, warfarin, enoxaparin, dalteparin), thrombolytic agents (reteplase and tenecteplase), factor Xa inhibitors such as apixaban, rivaroxaban, edoxaban, betrixaban, thrombin inhibitors such as dabigatran.

There are approx. 10+ key companies developing therapies for Venous Thromboembolism. Currently, Quercis Pharma is leading the therapeutics market with its Venous Thromboembolism drug candidates in the most advanced stage of clinical development.

Venous Thromboembolism Companies in the Therapeutics Market Include:
• Quercis Pharma
• Ono Pharmaceutical
• Anthos Therapeutics
• Bristol Myers Squibb
• Yuhan Corporation
• Supergene
• Tasly Pharmaceutical
• GlycoMimetics
And Many Others

Emerging and Marketed Venous Thromboembolism Therapies Covered in the Report Include:
• Isoquercetin: Quercis Pharma
• Abelacimab: Anthos therapeutics
And Many More

Get an in-depth Assessment of the Emerging Therapies and Venous Thromboembolism Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/venous-thromboembolism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Venous Thromboembolism Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Venous Thromboembolism pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Venous Thromboembolism Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/venous-thromboembolism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Venous Thromboembolism Current Treatment Patterns
4. Venous Thromboembolism - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Venous Thromboembolism Late-Stage Products (Phase-III)
7. Venous Thromboembolism Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Venous Thromboembolism Discontinued Products
13. Venous Thromboembolism Product Profiles
14. Venous Thromboembolism Companies
15. Venous Thromboembolism Drugs
16. Dormant and Discontinued Products
17. Venous Thromboembolism Unmet Needs
18. Venous Thromboembolism Future Perspectives
19. Venous Thromboembolism Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/venous-thromboembolism-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Schizophrenia Market
https://www.delveinsight.com/report-store/schizophrenia-market

Human Immunodeficiency Virus Type-1 (HIV-1) Market
https://www.delveinsight.com/report-store/human-immunodeficiency-virus-type-1-hiv-1-market

US Healthcare Outlook Bulimia Nervosa Market
https://www.delveinsight.com/report-store/bulimia-nervosa-market

Hepatitis B Virus (HBV) Infection Market
https://www.delveinsight.com/report-store/hepatitis-b-virus-hbv-infection-market

Pancreatic Cancer Market
https://www.delveinsight.com/report-store/pancreatic-cancer-market

Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market

Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market

Cytomegalovirus (CMV) Infections Market
https://www.delveinsight.com/report-store/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast

Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market

Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market

Giant-Cell Arteritis Market
https://www.delveinsight.com/report-store/giant-cell-arteritis-market

Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market

Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market

Patent Foramen Ovale (PFO) Closure Devices Market
https://www.delveinsight.com/report-store/patent-foramen-ovale-closure-devices-market

Invasive Pneumococcal Disease Market
https://www.delveinsight.com/report-store/invasive-pneumococcal-disease-market

Echocardiography Devices Market
https://www.delveinsight.com/report-store/echocardiography-devices-market

Primary Immune Deficiency (PID) Market
https://www.delveinsight.com/report-store/primary-immune-deficiency-pid-market

Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market

Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market

Postoperative Nausea and Vomiting (PONV) Market
https://www.delveinsight.com/report-store/postoperative-nausea-and-vomiting-ponv-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market

Hemodynamic Monitoring Systems Market
https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market

Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market

Food Allergy Market
https://www.delveinsight.com/report-store/food-allergy-market-insights

Embolotherapy Market
https://www.delveinsight.com/report-store/embolotherapy-market

Psychosis Market
https://www.delveinsight.com/report-store/psychosis-market

Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market

Asthma Market
https://www.delveinsight.com/report-store/asthma-market

Spinal Non-Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-non-fusion-devices-market

Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market

Myasthenia Gravis Market
https://www.delveinsight.com/report-store/myasthenia-gravis-market

Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market

Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market

Injectable Drug Delivery Devices Market
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market

Atherectomy Devices Market
https://www.delveinsight.com/report-store/atherectomy-devices-market

Chemotherapy Induced Nausea and Vomiting Market
https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-market

Structural Heart Devices Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market

Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market

Tissue Heart Valves Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market

Cardiovascular Prosthetic Devices Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market

Diabetic Macular Edema (DME) Market
https://www.delveinsight.com/report-store/diabetic-macular-edema-dme-market

End-Stage Renal Disease (ESRD) Market
https://www.delveinsight.com/report-store/end-stage-renal-disease-esrd-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market

Diabetic Retinopathy Market
https://www.delveinsight.com/report-store/diabetic-retinopathy-market

Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market

Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market

Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Thromboembolism Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Quercis, Ono Pharma, Anthos, Bristol Myers Squibb, Yuhan Corp, Supergene, Tasly, GlycoMimetics here

News-ID: 3247959 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Venous

States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%. Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period. Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size? Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period. The current outlook for the venous catheter market is positive, driven by factors such as
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism. Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188 Pulmonary embolism occurs in almost one-third of patients
Venous Thromboembolism Treatment Market Analysis by 2028
Global Venous Thromboembolism Treatment Market: Overview When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts. A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing